by PharmacyChecker.com | Oct 11, 2010 | Drug Prices, Healthcare Reform, Medicare Drug Plans
With open enrollment for Medicare Part D just around the corner, 50% discounts on brand name prescriptions while in the coverage gap seems to be a great new benefit this coming year… or is it? Some patient advocate groups, and we at PharmacyChecker.com, are asking, 50% off what price? Will PhRMA offer the discount on a higher-than-normal base price to cover their losses?
As the market, not the government, controls drug prices, it is a possibility that manufacturers will up the prices on drugs, especially specialty medications that lack brand-name alternative or generic competition, in order to make up for the lost profit. A brand name drug that costs $100 per month now – $50 in 2011 for Medicare Part D enrollees – may likely cost $120 next year – or $60 for Medicare enrollees – so that the manufacturers are able to spare revenue loss little by little. (more…)
Tagged with: affordable prescriptions, Drug Prices, health, Healthcare Reform, Medicare, Medicare Drug Plans, Part D, phrma, save money, seniors, United States
by Tod Cooperman, MD, President, PharmacyChecker.com, and Gabriel Levitt, Vice President, PharmacyChecker.com | Sep 21, 2010 | Online Pharmacies
The letter below is an updated version of the one mailed on September 13th.
September 13th, 2010
Mr. John O. Jeffery
General Counsel
Internet Corporation for Assigned Names and Numbers
4676 Admiralty Way, Suite 330
Marina del Rey, CA 90292-6601
RE: White House meeting to discuss online pharmacies
Dear John –
We are the president and vice president of PharmacyChecker.com, the leading online verification company for U.S. and international online pharmacies. We learned recently of the White House meeting scheduled for September 29th intended to focus on “voluntary protocols to address the illegal online sale of counterfeit non-controlled prescription medication” (the “Meeting”).
The broader legal and policy issues affecting whether and when ICANN and its members should accede to government requests to deny or cancel domain name registrations is a very serious one for the future of the internet, and is generally beyond our purview. Our purpose is to set out for you and your members some considerations that should affect your evaluation of whatever may be presented at the Meeting. We request that you make this letter available to all members invited to or attending the Meeting. The letter is necessarily in summary form, and we would be pleased to provide upon request additional information that may assist you. (more…)
Tagged with: FDA, ICANN, John O. Jeffery, Joseph Biden, NABP, United States, voluntary agreements, White House
